p53 expression status is a significant molecular marker in predicting the time to endocrine therapy failure in recurrent breast cancer : a cohort study

スポンサーリンク

概要

論文の詳細を見る
2006-12-01

著者

関連論文

Immunohistochemical Evaluation of Hormone Receptor Status for Predicting Response to Endocrine Therapy in Metastatic Breast Cancer
Consecutively Occurring Multiple Fibroadenomas of the Breast Distinguished from Phyllodes Tumors by Clonality Analysis of Stromal Tissue
CD44^+ slow-cycling tumor cell expansion is triggered by cooperative actions of Wnt and prostaglandin E_2 in gastric tumorigenesis
Teratoid carcinosarcoma of the ovary with prominent neuroectodermal differentiation
Ovarian yolk sac tumor with virilization during pregnancy : Immunohistochemical demonstration of Leydig cells as functioning stroma
Myoepithelioma of soft tissue
Endometrial stromal sarcoma of the uterus with rhabdoid features
Pathological lymph node involvement at surgery is a significant predictive factor of recurrence in locally advanced breast cancer treated with concomitant epirubicin-docetaxel neoadjuvant chemotherapy : a cohort study
Mouse mammary gland reconstitution with extrinsic gene-transferred mammary epithelial cells in vitro and in vivo
p53 expression status is a significant molecular marker in predicting the time to endocrine therapy failure in recurrent breast cancer : a cohort study
Current topics and perspectives in the treatment of endocrine-related cancers
Higher Plasma Vascular Endothelial Growth Factor Levels Correlate with Menopause, Overexpression of p53, and Recurrence of Breast Cancer
An Evaluation of Predictive Factors Involved in Clinical or Pathological Response to Primary Chemotherapy in Advanced Breast Cancer
Is triple negative a prognostic factor in breast cancer?
Overexpression of p21Waf1 Induces Apoptosis in Immortalized Human Vascular Smooth Muscle Cells
Breast cancer stem cells
Predictors of response to exemestane as primary endocrine therapy in estrogen receptor-positive breast cancer
Maintenance of HCT116 colon cancer cell line conforms to a stochastic model but not a cancer stem cell model
Cyclin-Dependent Kinase Inhibitor, p21Waf1, Regulates Vascular Smooth Muscle Cell Hypertrophy
Clinical significance of Ki-67 in neoadjuvant chemotherapy for primary breast cancer as a predictor for chemosensitivity and for prognosis
Trastuzumab monotherapy versus combination therapy for treating recurrent breast cancer : time to progression and survival
Extended Indication Criteria for Endoscopic Mucosal Resection of Early Gastric Cancer with Special Reference to Lymph Node Metastasis : Examination by Multivariate Analysis
Mucocele-like tumor associated with ductal carcinoma in situ diagnosed as mucinous carcinoma by fine-needle aspiration cytology : report of a case
Epstein-Barr Virus-Negative Classical Hodgkin's Lymphoma in a Patient with T-Cell Prolymphocytic Leukemia Treated with Fludarabine
Time to first tumor progression as a predictor of efficacy of continued treatment with trastuzumab beyond progression in human epidermal growth factor receptor 2-positive metastatic breast cancer
Pigment Epithelium-derived Factor as a New Diagnostic Marker for Melanocytic Tumors
A Case of Malignant Lymphoma with Hemophagocytic Syndrome Presenting as Hepatic Failure.

もっと見る

スポンサーリンク